INOVIO Says VOCERYQ Granted Accelerated Approval
INOVIO reported that VOCERYQ (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) was granted accelerated approval.
Related stories
Modi’s Office Summons Telecom Secretary Over Fake Court Orders
Two government officials said the summons followed takedowns of more than 100 websites based on fake court orders.
L impact | REGULATION | Nov 14, 2026, 09:10 AM UTC
Modi’s Office Summons Telecom Secretary Over Website Takedowns
Government sources say the summons follows Reuters revelations that website takedowns were based on fake court orders.
M impact | REGULATION | Nov 14, 2026, 07:58 AM UTC
China Says Both Sides Discussed Reciprocal Tariff Cuts Worth $30 Billion Each
China’s Commerce Ministry said the sides discussed tariffs, reciprocal tariff cuts worth $30 billion on each side, agricultural trade and other issues.
L impact | REGULATION | Nov 14, 2026, 06:56 AM UTC
China to Add Pfizer GLP-1 Drug to State Health Insurance Scheme
M impact | REGULATION | Nov 14, 2026, 06:02 AM UTC
China to Add JW Therapeutics’ CAR-T Therapy to State Insurance
China’s National Healthcare Security Administration says JW Therapeutics’ CAR-T therapy will be added to the state-run health insurance scheme.
L impact | REGULATION | Nov 14, 2026, 03:03 AM UTC
China to Add JW Therapeutics CAR-T Therapy to State Health Insurance
China's National Healthcare Security Administration says JW Therapeutics' CAR-T therapy will be added to the state-run health insurance scheme.
M impact | REGULATION | Nov 14, 2026, 03:03 AM UTC